Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | ![]() Viewpoint Molecular Targeting Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer. | |
Founding Date | Founding Date 2016 | Founding Date 2008 |
Type | Type Private | Type Subsidiary |
Tags | ||
Locations | Locations Tucson, US HQ | Locations Coralville, US HQ |
Employees | Employees 1220% increase | Employees 517% decrease |
Funding | ||
Total funding raised | Total funding raised $ 1.6m | Total funding raised $ 300k |

Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer.
View company